Skip to main content
Premium Trial:

Request an Annual Quote

Incyte, Amersham Partner to Provide Genomic Data for Microarray Research

Premium

Genomic database company Incyte Genomics of Palo Alto, Calif., and Amersham Pharmacia Biotech of Sunnyvale, Calif., recently announced an alliance to provide scientists with genomic content for microarray research.

Under the terms of the non-exclusive agreement, Amersham Pharmacia Biotech will be the first company to offer Incyte’s Easy-to-Spot pre-assembled set of non-proprietary human and mouse clones. Amersham Pharmacia Biotech will offer the sequences in a format customized for the company’s Generation III microarray products.

The financial terms of the deal were not disclosed.

Filed under

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.